Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-03-06
1998-02-17
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544250, 562426, 562439, 562451, A61K 31495, C07D48706, C07D47106, C07D21548
Patent
active
057191522
ABSTRACT:
A tricyclic quinoxalinedione derivative represented by the formula 1: ##STR1## wherein X represents hydrogen, alkyl, halogen, cyano, trifluoromethyl, or nitro;
REFERENCES:
patent: 3813392 (1974-05-01), Sellstedt et al.
patent: 4075206 (1978-02-01), Holmes
patent: 5616586 (1997-04-01), Nagata
Frontiers in Excitatory Amino Acid Research, pp. 203-210 (1988).
Brain's Diseases of the Nervous System, seventh edition, Oxford University Press, pp. 926-927 (1969).
Annual Reports in Medicinal Chemistry-21, Academic Press, Inc., Chapter 27, Bioisosterism in Drug Design, pp. 283-291 (1986).
Annual Reports in Medicinal Chemistry-10, Academic Press, Inc., Chapter 31, Prodrug Approach in Drug Design, pp. 306-316 (1975).
The New England Journal of Medicine, 330, 613-622, 1994.
The Journal of Pharmacology and Experimental Therapeutics, 264, 1248-1252, 1993.
Stroke, 25, 255, 1994.
Journal of Cerebral Blood Flow and Metabolism, 11, 786-793, 1991.
Eckard Webber, Antagonist at the Glycine Coagonist Site of the NMDA Receptor--In Vivo Efficacy Profiles in Animal Models of Stroke, Cambridge Healthtech Institute, Waltham, MA (1994).
Richardson et al. (1959) J. Org. Chem. 25:1138-47.
Pellegrini-Giampietro et al. (1989) Br. J. Pharmacol 98:1281-86.
Sheardown et al. (1989) Eur. J. of Pharmacology 174:197-204.
Yoneda et al. (1989) Biochem. and Biophys. Research Comm. 164(2):841-49.
Sheardown et al. (1990) Science 247:571-74.
Isoda et al. (1980) Chem. Pharm. Bull. 28(8):2337-46.
Journal of Cerebral Blood Flow and Metabolism, 11, (Suppl. 2), S304, 1992.
Pain, 51, No. 2, 249-253, 1992.
Br. J. Clin. Pharmac., 34, 106-114, 1992.
The Journal of Pharmacology and Experimental Therapeutics, 264, 256-264, 1993.
A. Richardson (1965) Journal of Organic Chemistry 30(8) :2589-93.
D. J. McNamara et al., J. Med. Chem. vol. 33, No. 7, 1990, pp. 2045-2051.
Ae Nobuyuki
Kodo Toru
Nagata Ryu
Tanno Norihiko
Yamaguchi Hiroshi
Berch Mark L.
Sumitomo Pharmaceuticals Co. Ltd.
LandOfFree
Tricyclic quinoxalinedione derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic quinoxalinedione derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic quinoxalinedione derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784187